Humacyte Inc

HUMANASDAQ · USD
0.56USD0.00 (-2.01%)
122

Humacyte Inc (HUMA) Unusual Options Activity Today

HUMA options volume power reached 0.05x on the previous trading day. The highest reading was on the $1 PUT expiring 2026-11-20.

Read more

Checking HUMA unusual options activity helps you spot when traders are making outsized bets on Humacyte Inc before the broader market catches on. Humacyte Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor HUMA unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching HUMA unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking HUMA unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and HUMA unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes.

The company was founded in 2004 and is headquartered in Durham, North Carolina.

Catalysts rarely arrive without a footprint, and HUMA unusual options activity is often where that footprint shows up first. Our scanner tracks Humacyte Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at HUMA unusual options volume on the call side or chasing put sweeps, Humacyte Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
0.50—0.400.40799%0150.00%
1.00—0.050.05258%0990.00%
1.50—0.050.05347%00—
2.00—0.050.05403%010.00%
Puts
0.50—0.050.05153%080.00%
1.00—0.800.80891%010.00%
1.500.351.500.9351%00—
2.00—4.004.001,000%00—

As of September 24, 2026

Spot unusual options activity before it moves

Track HUMA options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial